Related Experiment Video
Updated: Jul 2, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Edoxaban in cardiovascular disease management: Review
Sharanyah Srinivasan1, Muhammad Ajmal2, Cristina Pecci3
1College of Medicine, University of Arizona, Tucson, Arizona, USA.
Abstract:
In the past decade, direct oral anticoagulants (DOACs) have transformed the world of anti-thrombotic therapy. Edoxaban is the most recently approved DOAC. Though intended for use primarily in stroke prevention, it has found applications in various other conditions including thromboembolic and peripheral arterial disease. This review aims to provide a detailed outline of the growing indications, evidence for use in special populations, pharmacogenetics and side-effect profile of edoxaban.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Atherosclerosis III: Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

